What is she best known for?
The fields of study she is best known for:
Her primary areas of study are Cell biology, Histone methyltransferase, Histone, Molecular biology and Histone methylation.
Her studies deal with areas such as Cancer cell and Epigenetics as well as Cell biology.
Her work carried out in the field of Histone methyltransferase brings together such families of science as Histone H2A, DNA methylation and Histone code.
Her research integrates issues of Chromatin remodeling and Histone-modifying enzymes in her study of Histone code.
Her research in Histone intersects with topics in Chromatin and Regulation of gene expression.
Her Molecular biology research is multidisciplinary, incorporating perspectives in TATA box, SAP30, Activator, Histone acetyltransferase activity and Transcription.
Her most cited work include:
- The complex language of chromatin regulation during transcription (2264 citations)
- Acetylation of Histones and Transcription-Related Factors (1488 citations)
- IDH mutation impairs histone demethylation and results in a block to cell differentiation (1332 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Cell biology, Histone, Chromatin, Epigenetics and Genetics.
Her Cell biology research includes elements of Molecular biology and Transcription, Transcription factor, Gene.
Her Histone study is focused on Biochemistry in general.
Her Chromatin research is multidisciplinary, incorporating elements of Enhancer, Regulation of gene expression and Chromatin immunoprecipitation.
Shelley L. Berger has researched Epigenetics in several fields, including Computational biology, Neuroscience, Disease and DNA methylation.
Her work deals with themes such as Epigenomics, EZH2 and Histone methylation, which intersect with Histone methyltransferase.
She most often published in these fields:
- Cell biology (45.29%)
- Histone (30.80%)
- Chromatin (28.62%)
What were the highlights of her more recent work (between 2017-2021)?
- Cell biology (45.29%)
- Chromatin (28.62%)
- Epigenetics (20.65%)
In recent papers she was focusing on the following fields of study:
Shelley L. Berger spends much of her time researching Cell biology, Chromatin, Epigenetics, Transcription factor and Gene.
The various areas that Shelley L. Berger examines in her Cell biology study include Enhancer, Transcription, Gene expression, Reprogramming and Regulation of gene expression.
Her Chromatin study integrates concerns from other disciplines, such as Cellular differentiation, Histone, DNA damage and Epigenome.
Her work investigates the relationship between Histone and topics such as Acetylation that intersect with problems in Nucleosome and Germ cell.
The Epigenetics study combines topics in areas such as Neuroscience, DNA methylation, Neurodegeneration, Disease and Computational biology.
Her Transcription factor study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Effector.
Between 2017 and 2021, her most popular works were:
- TOX transcriptionally and epigenetically programs CD8 + T cell exhaustion (376 citations)
- Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-targeted T-cells (303 citations)
- TCF-1-Centered Transcriptional Network Drives an Effector Versus Exhausted CD8 T Cell-Fate Decision (173 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in Cell biology, Chromatin, Epigenetics, Histone and Regulation of gene expression.
Her Cell biology study incorporates themes from Transcription, Transcription factor, Gene expression and Immune system.
Her Transcription factor study combines topics in areas such as Cytotoxic T cell and Effector.
As a member of one scientific family, Shelley L. Berger mostly works in the field of Chromatin, focusing on Epigenome and, on occasion, Histone H3, Motility, Andrology and Semen.
Her Epigenetics research integrates issues from Neurodegeneration, Disease, Enhancer, Epigenomics and Neuroscience.
Her Regulation of gene expression study incorporates themes from Acetylation, CRISPR and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
